Sci Pharmtech (TPE:4119) Accounts Payable & Accrued Expense : NT$275 Mil (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Sci Pharmtech Accounts Payable & Accrued Expense?

Sci Pharmtech's quarterly accounts payable & accrued expense declined from Sep. 2023 (NT$336 Mil) to Dec. 2023 (NT$294 Mil) and declined from Dec. 2023 (NT$294 Mil) to Mar. 2024 (NT$275 Mil).

Sci Pharmtech's annual accounts payable & accrued expense increased from Dec. 2021 (NT$281 Mil) to Dec. 2022 (NT$509 Mil) but then declined from Dec. 2022 (NT$509 Mil) to Dec. 2023 (NT$294 Mil).

Sci Pharmtech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Sci Pharmtech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sci Pharmtech Accounts Payable & Accrued Expense Chart

Sci Pharmtech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

437.41

418.37

280.72

509.11

294.17

Sci Pharmtech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															393.43	405.54	336.37	294.17	275.42

Sci Pharmtech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Sci Pharmtech (TPE:4119) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sci Pharmtech Inc (TPE:4119) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856

Website

http://www.sci-pharmtech.com.tw

Sci Pharmtech Inc is engaged in research and development, manufacture and sale of active pharmaceutical ingredients, intermediates, specialty chemicals. Geographically, the primary markets of company are Italy, Germany, Japan, Taiwan, United states, China, Switzerland, Spain and others.

Sci Pharmtech (TPE:4119) Headlines

No Headlines